SG147476A1 - Bicyclic pyrazolone cytokine inhibitors - Google Patents
Bicyclic pyrazolone cytokine inhibitorsInfo
- Publication number
- SG147476A1 SG147476A1 SG200808004-6A SG2008080046A SG147476A1 SG 147476 A1 SG147476 A1 SG 147476A1 SG 2008080046 A SG2008080046 A SG 2008080046A SG 147476 A1 SG147476 A1 SG 147476A1
- Authority
- SG
- Singapore
- Prior art keywords
- cytokine inhibitors
- pyrazolo
- pyrazol
- dihydro
- ones
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51888603P | 2003-11-10 | 2003-11-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG147476A1 true SG147476A1 (en) | 2008-11-28 |
Family
ID=34590314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200808004-6A SG147476A1 (en) | 2003-11-10 | 2004-11-09 | Bicyclic pyrazolone cytokine inhibitors |
Country Status (18)
Country | Link |
---|---|
US (2) | US7482356B2 (pt) |
EP (1) | EP1682551A2 (pt) |
JP (1) | JP2007510739A (pt) |
KR (1) | KR100835152B1 (pt) |
CN (1) | CN1878772A (pt) |
AR (1) | AR046618A1 (pt) |
AU (1) | AU2004289691B2 (pt) |
BR (1) | BRPI0416358A (pt) |
CA (1) | CA2545781A1 (pt) |
IL (1) | IL175151A0 (pt) |
MA (1) | MA28154A1 (pt) |
NO (1) | NO20062639L (pt) |
PE (1) | PE20050578A1 (pt) |
RU (1) | RU2358976C2 (pt) |
SG (1) | SG147476A1 (pt) |
TW (1) | TW200518754A (pt) |
WO (1) | WO2005047287A2 (pt) |
ZA (1) | ZA200603582B (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101182114B1 (ko) * | 2010-03-05 | 2012-09-12 | 한림제약(주) | 유효성분으로서 레바미피드를 함유하는 골관절염 예방 또는 치료용 약학 조성물 |
AR110401A1 (es) * | 2016-12-21 | 2019-03-27 | Chiesi Farm Spa | Derivados dihidropirimidina bicíclica-carboxamida como inhibidores de rho-quinasa |
CN115286635B (zh) * | 2022-08-22 | 2023-10-24 | 河南师范大学 | 一种手性并环吡唑啉酮类化合物的合成方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1124982A (en) | 1965-02-09 | 1968-08-21 | Lepetit Spa | Diazabicyclo octanes and derivatives thereof |
CH529154A (fr) | 1969-10-27 | 1972-10-15 | Lepetit Spa | Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones |
US6472416B1 (en) | 1999-08-27 | 2002-10-29 | Abbott Laboratories | Sulfonylphenylpyrazole compounds useful as COX-2 inhibitors |
US6849627B2 (en) * | 2001-09-20 | 2005-02-01 | The Procter & Gamble Company | 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
US6730668B2 (en) | 2001-09-20 | 2004-05-04 | The Procter & Gamble Company | 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
US7087615B2 (en) * | 2001-09-20 | 2006-08-08 | The Procter & Gamble Company | 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which provide analgesia |
US6821971B2 (en) | 2001-09-20 | 2004-11-23 | The Procter & Gamble Company | Fused pyrazolone compounds which inhibit the release of inflammatory cytokines |
US6677337B2 (en) | 2002-03-19 | 2004-01-13 | The Procter & Gamble Company | 1,2-dihydropyrazol-3-ones which controls inflammatory cytokines |
-
2004
- 2004-11-05 US US10/983,114 patent/US7482356B2/en not_active Expired - Fee Related
- 2004-11-09 SG SG200808004-6A patent/SG147476A1/en unknown
- 2004-11-09 BR BRPI0416358-3A patent/BRPI0416358A/pt not_active IP Right Cessation
- 2004-11-09 EP EP04810572A patent/EP1682551A2/en not_active Withdrawn
- 2004-11-09 WO PCT/US2004/037264 patent/WO2005047287A2/en active Application Filing
- 2004-11-09 AU AU2004289691A patent/AU2004289691B2/en not_active Expired - Fee Related
- 2004-11-09 RU RU2006114580/04A patent/RU2358976C2/ru not_active IP Right Cessation
- 2004-11-09 JP JP2006539725A patent/JP2007510739A/ja active Pending
- 2004-11-09 KR KR1020067008849A patent/KR100835152B1/ko not_active IP Right Cessation
- 2004-11-09 AR ARP040104133A patent/AR046618A1/es not_active Application Discontinuation
- 2004-11-09 PE PE2004001091A patent/PE20050578A1/es not_active Application Discontinuation
- 2004-11-09 CN CNA2004800328398A patent/CN1878772A/zh active Pending
- 2004-11-09 CA CA002545781A patent/CA2545781A1/en not_active Abandoned
- 2004-11-10 TW TW093134336A patent/TW200518754A/zh unknown
-
2006
- 2006-04-24 IL IL175151A patent/IL175151A0/en unknown
- 2006-05-05 ZA ZA200603582A patent/ZA200603582B/en unknown
- 2006-05-11 MA MA29018A patent/MA28154A1/fr unknown
- 2006-06-08 NO NO20062639A patent/NO20062639L/no not_active Application Discontinuation
-
2008
- 2008-11-06 US US12/291,084 patent/US20090069355A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN1878772A (zh) | 2006-12-13 |
JP2007510739A (ja) | 2007-04-26 |
RU2358976C2 (ru) | 2009-06-20 |
CA2545781A1 (en) | 2005-05-26 |
NO20062639L (no) | 2006-06-08 |
ZA200603582B (en) | 2007-04-25 |
IL175151A0 (en) | 2006-09-05 |
AR046618A1 (es) | 2005-12-14 |
PE20050578A1 (es) | 2005-09-26 |
MA28154A1 (fr) | 2006-09-01 |
EP1682551A2 (en) | 2006-07-26 |
WO2005047287A3 (en) | 2005-07-28 |
US20090069355A1 (en) | 2009-03-12 |
US7482356B2 (en) | 2009-01-27 |
AU2004289691B2 (en) | 2009-04-23 |
KR100835152B1 (ko) | 2008-06-09 |
KR20060086391A (ko) | 2006-07-31 |
BRPI0416358A (pt) | 2007-05-08 |
AU2004289691A1 (en) | 2005-05-26 |
RU2006114580A (ru) | 2007-12-20 |
US20050113392A1 (en) | 2005-05-26 |
TW200518754A (en) | 2005-06-16 |
WO2005047287A2 (en) | 2005-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20074078B (en) | Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use | |
EP1485381B8 (en) | Azolylaminoazine as inhibitors of protein kinases | |
WO2005118544A3 (en) | Cycloalkyl substituted pyrimidinediamine compounds and their uses | |
TW200616632A (en) | Compounds modulating c-kit activity and uses therefor | |
AU2003220299A1 (en) | Azinylaminoazoles as inhibitors of protein kinases | |
AU2003220300A1 (en) | Compositions useful as inhibitors of protein kinases | |
TW200510328A (en) | 5-membered heterocycle-based p38 kinase inhibitors | |
TW200630096A (en) | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity | |
WO2001064214A3 (en) | Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors | |
WO2004080406A3 (en) | Therapeutic compositions | |
MY135856A (en) | Nicotinamide derivatives useful as pde4 inhibitors | |
WO2008002571A3 (en) | Human protein tyrosine phosphatase inhibitors and methods of use | |
AU3227700A (en) | Skin sanitizing compositions | |
WO2006019881A3 (en) | Compositions and methods for controlling biofilms and bacterial infections | |
WO2006063031A3 (en) | Allelic variants of human factor viii | |
AU2002233928A1 (en) | Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases | |
WO2002068476A3 (en) | Composition comprising il-22 inhibitors and use thereof for treating inflammatory disorders | |
AU2003232115A1 (en) | Methods and compositions for the treatment of graft failure | |
IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
NO20062639L (no) | Bicykliske pyraxoloncytokininhibitorer | |
IL173886A0 (en) | Alpha-aminoamide derivatives useful as anti-inflammatory agents | |
WO2003066000A3 (en) | Formulation comprising bioactive agents and method of using same | |
WO2004021992A3 (en) | Delivery of therapeutics to the brain and spinal cord | |
WO2002036136A3 (en) | Compositions and methods for prolonging survival of chilled platelets | |
WO2001060320A3 (en) | Treatment of inflammation with p20 |